Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning

摘要

Background: Chelation therapy has been used as a means of reducing the body burden of lead for five decades. Intravenous sodium calcium edetate has been the preferred agent, but there is increasing evidence that dimercaptosuccinic acid (DMSA) is also a potent chelator of lead.